Cargando…

Ovarian Hyperstimulation Syndrome Caused by Functional Gonadotroph Pituitary Adenoma

Functional gonadotroph adenomas (FGAs) are rare, manifesting symptoms like menstrual irregularities or ovarian hyperstimulation syndrome (OHSS). We present a case of OHSS caused by an FGA during the follow-up of a pituitary tumor initially considered nonfunctioning. The patient presented with lower...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsukaguchi, Ryo, Hasebe, Masashi, Honjo, Sachiko, Hamasaki, Akihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580461/
https://www.ncbi.nlm.nih.gov/pubmed/37908987
http://dx.doi.org/10.1210/jcemcr/luad087
_version_ 1785121945157632000
author Tsukaguchi, Ryo
Hasebe, Masashi
Honjo, Sachiko
Hamasaki, Akihiro
author_facet Tsukaguchi, Ryo
Hasebe, Masashi
Honjo, Sachiko
Hamasaki, Akihiro
author_sort Tsukaguchi, Ryo
collection PubMed
description Functional gonadotroph adenomas (FGAs) are rare, manifesting symptoms like menstrual irregularities or ovarian hyperstimulation syndrome (OHSS). We present a case of OHSS caused by an FGA during the follow-up of a pituitary tumor initially considered nonfunctioning. The patient presented with lower abdominal pain, abdominal swelling, and dyspnea. Magnetic resonance imaging (MRI) revealed 15 cm enlarged ovarian cysts and pleural effusion. Laboratory examination showed an elevated serum estradiol (E2) level (5741.4 pmol/L [1564.0 pg/mL]), suppressed luteinizing hormone, and nonsuppressed follicular-stimulating hormone (FSH). However, no pituitary hormone disorders were observed when a 19 mm pituitary tumor was discovered 11 months prior. Given the absence of human chorionic gonadotropin (hCG) administration, OHSS due to the FGA was suspected. Cabergoline, known for alleviating the severity of OHSS, was administered, but the ovarian cysts continued to enlarge. Subsequently, endoscopic transsphenoidal surgery was performed, and immunohistochemical analysis confirmed the diagnosis of the FSH-producing adenoma. Follow-up MRI scans showed reduced ovarian cysts and successful pituitary tumor resection with a reduced E2 level. This case highlights the importance of considering FGAs when encountering OHSS without hCG administration or following up on pituitary tumors in premenopausal female patients to take appropriate measures for accurate diagnosis and management.
format Online
Article
Text
id pubmed-10580461
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-105804612023-10-31 Ovarian Hyperstimulation Syndrome Caused by Functional Gonadotroph Pituitary Adenoma Tsukaguchi, Ryo Hasebe, Masashi Honjo, Sachiko Hamasaki, Akihiro JCEM Case Rep Case Report Functional gonadotroph adenomas (FGAs) are rare, manifesting symptoms like menstrual irregularities or ovarian hyperstimulation syndrome (OHSS). We present a case of OHSS caused by an FGA during the follow-up of a pituitary tumor initially considered nonfunctioning. The patient presented with lower abdominal pain, abdominal swelling, and dyspnea. Magnetic resonance imaging (MRI) revealed 15 cm enlarged ovarian cysts and pleural effusion. Laboratory examination showed an elevated serum estradiol (E2) level (5741.4 pmol/L [1564.0 pg/mL]), suppressed luteinizing hormone, and nonsuppressed follicular-stimulating hormone (FSH). However, no pituitary hormone disorders were observed when a 19 mm pituitary tumor was discovered 11 months prior. Given the absence of human chorionic gonadotropin (hCG) administration, OHSS due to the FGA was suspected. Cabergoline, known for alleviating the severity of OHSS, was administered, but the ovarian cysts continued to enlarge. Subsequently, endoscopic transsphenoidal surgery was performed, and immunohistochemical analysis confirmed the diagnosis of the FSH-producing adenoma. Follow-up MRI scans showed reduced ovarian cysts and successful pituitary tumor resection with a reduced E2 level. This case highlights the importance of considering FGAs when encountering OHSS without hCG administration or following up on pituitary tumors in premenopausal female patients to take appropriate measures for accurate diagnosis and management. Oxford University Press 2023-07-14 /pmc/articles/PMC10580461/ /pubmed/37908987 http://dx.doi.org/10.1210/jcemcr/luad087 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Tsukaguchi, Ryo
Hasebe, Masashi
Honjo, Sachiko
Hamasaki, Akihiro
Ovarian Hyperstimulation Syndrome Caused by Functional Gonadotroph Pituitary Adenoma
title Ovarian Hyperstimulation Syndrome Caused by Functional Gonadotroph Pituitary Adenoma
title_full Ovarian Hyperstimulation Syndrome Caused by Functional Gonadotroph Pituitary Adenoma
title_fullStr Ovarian Hyperstimulation Syndrome Caused by Functional Gonadotroph Pituitary Adenoma
title_full_unstemmed Ovarian Hyperstimulation Syndrome Caused by Functional Gonadotroph Pituitary Adenoma
title_short Ovarian Hyperstimulation Syndrome Caused by Functional Gonadotroph Pituitary Adenoma
title_sort ovarian hyperstimulation syndrome caused by functional gonadotroph pituitary adenoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580461/
https://www.ncbi.nlm.nih.gov/pubmed/37908987
http://dx.doi.org/10.1210/jcemcr/luad087
work_keys_str_mv AT tsukaguchiryo ovarianhyperstimulationsyndromecausedbyfunctionalgonadotrophpituitaryadenoma
AT hasebemasashi ovarianhyperstimulationsyndromecausedbyfunctionalgonadotrophpituitaryadenoma
AT honjosachiko ovarianhyperstimulationsyndromecausedbyfunctionalgonadotrophpituitaryadenoma
AT hamasakiakihiro ovarianhyperstimulationsyndromecausedbyfunctionalgonadotrophpituitaryadenoma